By attending 6th Annual Pain Management conference, you will acquire distilled, market-focussed intelligence from outstanding speakers in key areas including:
• Rational approaches to chronic pain management with opioids and new FDA risk evaluation and mitigation strategy guidelines
• Clinical results from human experimental pain models in early drug development
• Genetic architecture of human pain perception and the molecular mechanisms underlying various types of pains
• New insights from voltage-gated sodium and calcium channel targets
• Emerging strategies in exploiting cannabinoid receptors agonists and their clinical results
• Development of novel NSAIDs and COX-2 inhibitors in the post-Vioxx era
• Adequate PoC for new mechanisms
• Biomarkers for pain– from model to clinic
• Neuroimaging tools for analgesic drug discovery
• Reducing the numbers of patients in human clinical trials by eliminating non-responders
• Novel treatments for peripheral neuropathies undergoing clinical trials
• Outcome studies for neuropathic pain treatments in clinical practice and their implications for drug development and study design
• Innovative methods for conducting proof-of-concept studies
• Monoclonal antibody therapies for osteoarthritis in Phase III clinical trials
• Laser technology as a novel technique in human pain research
• The future market landscape in chronic pain
• New insights into migraine pain and the molecular basis of effective therapeutics

Conference on 6th Annual Pain Management To be held at 14th - 15th October 2009, BSG Conference Centre, London, UK Price GBP£ 1493.85